Historical record - last NADAC effective date: 11/17/2021
Product Information
PHAZYME 180 MG SOFTGEL is a brand product labeled by C.B. Fleet Company, Inc., priced at $0.2280 per EA under NDC 00132020812. Its NADAC has been published 112 times since Jun 3, 2020.
The High Outlier badge above means this manufacturer's average price in the Simethicone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
180 mg/1
Manufacturer
C.B. Fleet Company, Inc.NDC
00132020812
Classification
Brand
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
11/17/2021
Active Ingredients
DIMETHICONEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M002On Market Since
2/1/2012
Pharmacological Classes
Price Statistics
The NADAC for PHAZYME 180 MG SOFTGEL has been published 112 times since Jun 3, 2020, and over the history we have for it it has declined 13.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2280 per EA |
|---|---|
| All-time high | $0.2625 (Jul 15, 2020) |
| All-time low | $0.2280 (Nov 17, 2021) |
| Median price | $0.2606 |
| Average price | $0.2453 |
| Largest weekly change | -12.5% (Nov 17, 2021) |
| Weeks tracked | 112 |
| Tracking since | Jun 3, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-12.5%
All
-13.1%
Last surveyed Nov 16, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
C.B. Fleet Company, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Simethicone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHAZYME 180 MG SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for PHAZYME 180 MG SOFTGEL, manufactured by C.B. Fleet Company, Inc., is $0.2280 per EA (NDC 00132020812), effective Nov 16, 2022.
How has the price of PHAZYME 180 MG SOFTGEL changed over time?
Over the history we have for it, the NADAC for PHAZYME 180 MG SOFTGEL has declined 13.1%. It has been tracked across 112 weekly CMS publications since Jun 3, 2020.
What are the highest and lowest recorded NADAC prices for PHAZYME 180 MG SOFTGEL?
Since Jun 3, 2020, the NADAC for PHAZYME 180 MG SOFTGEL has ranged from a low of $0.2280 (Nov 17, 2021) to a high of $0.2625 (Jul 15, 2020), with a median of $0.2606 per EA.
Are there cheaper alternatives to PHAZYME 180 MG SOFTGEL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ANTI-GAS 180 MG SOFTGEL, is $0.0541 per EA — about 76% below PHAZYME 180 MG SOFTGEL.
Who manufactures PHAZYME 180 MG SOFTGEL?
PHAZYME 180 MG SOFTGEL (NDC 00132020812) is labeled by C.B. Fleet Company, Inc., and CMS classifies it as a brand product.